Tue 23 July 2024 | Jacob Celermajer
Medtech: a growth engine to diversify your portfolio
The core thesis behind an investment in medical technology is threefold; i) medtech has returned 14.1% p.a. (USD) over the past decade, and is still only in the early stages of a long-term secular trend, ii) medtech is underwritten by strong demographic tailwinds and oligopolistic industry structure, driving top-line growth and bottom-line profitability, and iii) it is a strong impact investment opportunity, promoting a healthier population and easing global financial burdens.